190 related articles for article (PubMed ID: 18496818)
1. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.
Lin CL; Lin JK
Mol Nutr Food Res; 2008 Aug; 52(8):930-9. PubMed ID: 18496818
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition.
Zhang ZF; Li Q; Liang J; Dai XQ; Ding Y; Wang JB; Li Y
Phytomedicine; 2010 Jan; 17(1):14-8. PubMed ID: 19819682
[TBL] [Abstract][Full Text] [Related]
3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
4. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells.
Cordero-Herrera I; Martín MÁ; Goya L; Ramos S
Food Chem Toxicol; 2014 Feb; 64():10-9. PubMed ID: 24262486
[TBL] [Abstract][Full Text] [Related]
5. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
6. Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells.
Deng YT; Chang TW; Lee MS; Lin JK
J Agric Food Chem; 2012 Feb; 60(4):1059-66. PubMed ID: 22191431
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells.
Cai EP; Lin JK
J Agric Food Chem; 2009 Oct; 57(20):9817-27. PubMed ID: 19803520
[TBL] [Abstract][Full Text] [Related]
8. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H
Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
[TBL] [Abstract][Full Text] [Related]
10. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
11. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
[TBL] [Abstract][Full Text] [Related]
12. Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways.
Hsieh CF; Tsuei YW; Liu CW; Kao CC; Shih LJ; Ho LT; Wu LY; Wu CP; Tsai PH; Chang HH; Ku HC; Kao YH
Planta Med; 2010 Oct; 76(15):1694-8. PubMed ID: 20455202
[TBL] [Abstract][Full Text] [Related]
13. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway.
Murase T; Misawa K; Haramizu S; Hase T
Biochem Pharmacol; 2009 Jul; 78(1):78-84. PubMed ID: 19447226
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice.
Latreille M; Laberge MK; Bourret G; Yamani L; Larose L
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E423-34. PubMed ID: 20587749
[TBL] [Abstract][Full Text] [Related]
16. [Epigallocatechin-3-gallate interferes with EBV-encoding AP-1 signal transduction pathway].
Zhao Y; Wang H; Zhao XR; Luo FJ; Tang M; Cao Y
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):393-7. PubMed ID: 15355641
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
Lin SK; Chang HH; Chen YJ; Wang CC; Galson DL; Hong CY; Kok SH
Arthritis Rheum; 2008 Oct; 58(10):3145-56. PubMed ID: 18821707
[TBL] [Abstract][Full Text] [Related]
18. Low salt intake modulates insulin signaling, JNK activity and IRS-1ser307 phosphorylation in rat tissues.
Prada PO; Coelho MS; Zecchin HG; Dolnikoff MS; Gasparetti AL; Furukawa LN; Saad MJ; Heimann JC
J Endocrinol; 2005 Jun; 185(3):429-37. PubMed ID: 15930169
[TBL] [Abstract][Full Text] [Related]
19. A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine.
Chao J; Lau WK; Huie MJ; Ho YS; Yu MS; Lai CS; Wang M; Yuen WH; Lam WH; Chan TH; Chang RC
Neurosci Lett; 2010 Jan; 469(3):360-4. PubMed ID: 20026175
[TBL] [Abstract][Full Text] [Related]
20. Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells.
Guo S; Lu J; Subramanian A; Sonenshein GE
Cancer Res; 2006 May; 66(10):5322-9. PubMed ID: 16707458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
